ArticleJournal of diabetes investigation2020

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study.

Ikuro Matsuba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.